A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
X-Cel Specialty Contacts and Essilor Custom Contacts announced Aug. 31 the US launch of Lunara, a new FDA-approved orthokeratology lens. Orthokeratology, or ortho-k, uses specially designed and fit...
The European Medical Journal reported Aug. 28 that artificial intelligence had provided real-time guidance for removal of a vision-threatening brain tumor at University College London Hospital (UCL...
SpyGlass Pharma celebrated the grand opening of its new Irvine, California, headquarters on Aug. 27, as the company continues to expand. SpyGlass was initially founded in Irvine in 2019 by Malik Y....
Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...
Basketball had the highest rate of sports-related eye injuries treated in the US in 2025, with 5,236 injuries, according to new statistics published Aug. 26 by Prevent Blindness. The Chicago, Illin...
The US FDA took inspiration from the way human clinicians are trained in drafting a proposal for the regulation of medical devices that feature generative artificial intelligence (GenAI), and it’s ...
Kiora Pharmaceuticals announced Aug. 10 that it had granted Chong Kun Dang (CKD) Pharmaceutical Corp. development and commercialization rights in South Korea to KIO-301 for the treatment of degener...
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.